Thomas Ressiniotis
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Thomas Ressiniotis has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Christopher Neoh
Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
1 shared publication - Gerasimos M Voros
Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom
1 shared publication Keith W. Mitchell
Regional Medical Physics Department, Royal Victoria Infirmary, Queen Victoria Road, Newcastle upon Tyne NE1 4LP, UK
1 shared publicationMichael Birch
1 shared publication- Michael Birch
Department of Ophthalmology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
1 shared publication Michael P. Clarke
Department of Ophthalmology
1 shared publication
Latest Publications
- Open Access
- 4 April 2005
- Published by Springer Nature in BMC Ophthalmology
- Vol. 5 (1) , 5
A polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians
Background: Primary open angle glaucoma (POAG) is considered to be a neurodegenerative optic neuropathy, in which cell death occurs by apoptosis. p21, is an important protective component of the apoptotic pathway, regulating cellular arrest in the presence of DNA damage. An unstable or altered p21 protein could modify the cellular response to genomic injury and abolish the effect of p21. A previous study on a Chinese cohort suggested that the p21 codon 31 polymorphism may alter the state of apoptosis in glaucomatous optic neuropathy, failing to protect the ganglion cells. The aim of this study was to test the hypothesis that a p21 codon 31 polymorphism is associated with POAG on a Caucasian cohort. Methods: 140 POAG patients and a control group of 73 healthy individuals were included in the study. All the subjects were of Caucasian origin. Genomic DNA was amplified by polymerase chain reaction, followed by enzymatic restriction fragment length polymorphism technique (PCR-RFLP). Patients and controls were genotyped for a single nucleotide polymorphism (C/A transversion) in the third base of codon 31 of p21, which leads to a serine (Ser)/arginine (Arg) substitution. Results: The distribution of the genotypes in the POAG patients showed 128 (91.4%) Ser homozygotes, 10 (7.1%) Ser/Arg heterozygotes and 2 (1.5%) Arg homozygotes. In the control cohort, there were 61 (83.6%) Ser homozygotes and 12 (16.4%) Ser/Arg heterozygotes. No Arg homozygotes were present amongst the control group. Both the allelic and genotypic frequencies of the Ser or Arg residues at codon 31 were not significantly different between POAG patients and controls (Fisher's exact test, P = 0.20 for alleles and P = 0.0561 for genotypes). Conclusion: This study suggests that the p21 codon 31 polymorphism does not contribute to the risk of POAG in the Caucasian population.
- 4 April 2005
- Published by Springer Nature in BMC Ophthalmology
- Vol. 5 (1) , 5
Open AccessA polymorphism at codon 31 of gene p21 is not associated with primary open angle glaucoma in Caucasians
Background: Primary open angle glaucoma (POAG) is considered to be a neurodegenerative optic neuropathy, in which cell death occurs by apoptosis. p21, is an important protective component of the apoptotic pathway, regulating cellular arrest in the presence of DNA damage. An unstable or altered p21 protein could modify the cellular response to genomic injury and abolish the effect of p21. A previous study on a Chinese cohort suggested that the p21 codon 31 polymorphism may alter the state of apoptosis in glaucomatous optic neuropathy, failing to protect the ganglion cells. The aim of this study was to test the hypothesis that a p21 codon 31 polymorphism is associated with POAG on a Caucasian cohort. Methods: 140 POAG patients and a control group of 73 healthy individuals were included in the study. All the subjects were of Caucasian origin. Genomic DNA was amplified by polymerase chain reaction, followed by enzymatic restriction fragment length polymorphism technique (PCR-RFLP). Patients and controls were genotyped for a single nucleotide polymorphism (C/A transversion) in the third base of codon 31 of p21, which leads to a serine (Ser)/arginine (Arg) substitution. Results: The distribution of the genotypes in the POAG patients showed 128 (91.4%) Ser homozygotes, 10 (7.1%) Ser/Arg heterozygotes and 2 (1.5%) Arg homozygotes. In the control cohort, there were 61 (83.6%) Ser homozygotes and 12 (16.4%) Ser/Arg heterozygotes. No Arg homozygotes were present amongst the control group. Both the allelic and genotypic frequencies of the Ser or Arg residues at codon 31 were not significantly different between POAG patients and controls (Fisher's exact test, P = 0.20 for alleles and P = 0.0561 for genotypes). Conclusion: This study suggests that the p21 codon 31 polymorphism does not contribute to the risk of POAG in the Caucasian population.
- Open Access
- 3 March 2005
- Published by Springer Nature in BMC Ophthalmology
- Vol. 5 (1) , 2
Clinical outcome of endonasal KTP laser assisted dacryocystorhinostomy
Background: To evaluate the clinical outcome of primary endonasal laser assisted dacryocystorhinostomy (ENL-DCR) using the potassium-titanyl-phosphate laser. Methods: We retrospectively reviewed all primary ENL-DCRs performed within a period of twelve months by the same combined Ophthalmology and Otorhinolaringology team in Freeman Hospital, Newcastle upon Tyne, UK. The main outcome measure for success was resolution or significant improvement of epiphora. Details of surgery, intraoperative and postoperative complications, as well as pathology associated with failure were also studied. Patients were followed up for at least 12 months. Results: A total of 41 consecutive ENL-DCRs on 29 patients (22 females, 7 males, mean age 75 years) were analysed. All patients had bicanalicular silicone intubation for at least 4 months. The success rate at 12 months postoperatively was 78.1%. Pathology associated with failure included: intranasal pathology (12.2%), mucocele (7.3%), and systemic sarcoidosis (2.4%). No significant intra-operative complications were recorded. Conclusion: The ENL-DCR with potassium-titanyl-phosphate laser can be considered as a safe and efficient primary procedure for the treatment of nasolacrimal duct obstruction.
- 3 March 2005
- Published by Springer Nature in BMC Ophthalmology
- Vol. 5 (1) , 2
Open AccessClinical outcome of endonasal KTP laser assisted dacryocystorhinostomy
Background: To evaluate the clinical outcome of primary endonasal laser assisted dacryocystorhinostomy (ENL-DCR) using the potassium-titanyl-phosphate laser. Methods: We retrospectively reviewed all primary ENL-DCRs performed within a period of twelve months by the same combined Ophthalmology and Otorhinolaringology team in Freeman Hospital, Newcastle upon Tyne, UK. The main outcome measure for success was resolution or significant improvement of epiphora. Details of surgery, intraoperative and postoperative complications, as well as pathology associated with failure were also studied. Patients were followed up for at least 12 months. Results: A total of 41 consecutive ENL-DCRs on 29 patients (22 females, 7 males, mean age 75 years) were analysed. All patients had bicanalicular silicone intubation for at least 4 months. The success rate at 12 months postoperatively was 78.1%. Pathology associated with failure included: intranasal pathology (12.2%), mucocele (7.3%), and systemic sarcoidosis (2.4%). No significant intra-operative complications were recorded. Conclusion: The ENL-DCR with potassium-titanyl-phosphate laser can be considered as a safe and efficient primary procedure for the treatment of nasolacrimal duct obstruction.
- Open Access
- 26 November 2004
- Published by Springer Nature in Eye
- Vol. 19 (12) , 1342-1343
Molteno tube obstruction due to viscoelastic after penetrating keratoplasty
- 26 November 2004
- Published by Springer Nature in Eye
- Vol. 19 (12) , 1342-1343
Open AccessMolteno tube obstruction due to viscoelastic after penetrating keratoplasty
- 1 February 2004
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 122 (2) , 258-261
The Role of Apolipoprotein E Gene Polymorphisms in Primary Open-angleGlaucoma
Research from JAMA Ophthalmology — The Role of Apolipoprotein E Gene Polymorphisms in Primary Open-angleGlaucoma
- 1 February 2004
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 122 (2) , 258-261
The Role of Apolipoprotein E Gene Polymorphisms in Primary Open-angleGlaucoma
Research from JAMA Ophthalmology — The Role of Apolipoprotein E Gene Polymorphisms in Primary Open-angleGlaucoma
- 3 November 2003
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 23 (6) , 513-516
Improved illumination for the Perkins applanation tonometer
Aims: To improve the Perkins tonometer measurements by using an augmented, monochromatic solid‐state light source of 470 nm wavelength. Methods: This prospective study comprised 44 patients of our ophthalmic department who were split into two groups of 21 and 23 patients, and were tested by two independent ophthalmologists. Intraocular pressure (IOP) was measured in both eyes, comparing the instrument with augmented source against the standard Perkins for both observers. A set of three consecutive IOP measurements was recorded on each patient's eye and the time required to make each of them was recorded. The mean of the three IOP values was used in the analyses. Results: For Observer 1, higher values of IOP with our augmented illumination against the standard were recorded, the mean difference of +0.59 mmHg being statistically significant (95% CI, 0.0 to +1.18 mmHg). For Observer 2, the mean difference of −0.22 mmHg was not significant (95% CI, −0.70 to +0.26 mmHg). Measurement times for observers were shorter when using the augmented illumination (Observer 1: mean difference = −2.0 s, S.E. = 1.4 s, CI, +0.8 to −4.9 s; Observer 2: mean difference = −5.0 s, S.E. = 1.3 s, CI, −2.5 to −7.5 s). Conclusion: The monochromatic blue light source may improve the performance of IOP measurements with the Perkins instrument under bright room conditions, making them faster and more convenient.
- 3 November 2003
- Published by Springer Nature in Ophthalmic and Physiological Optics
- Vol. 23 (6) , 513-516
Improved illumination for the Perkins applanation tonometer
Aims: To improve the Perkins tonometer measurements by using an augmented, monochromatic solid‐state light source of 470 nm wavelength. Methods: This prospective study comprised 44 patients of our ophthalmic department who were split into two groups of 21 and 23 patients, and were tested by two independent ophthalmologists. Intraocular pressure (IOP) was measured in both eyes, comparing the instrument with augmented source against the standard Perkins for both observers. A set of three consecutive IOP measurements was recorded on each patient's eye and the time required to make each of them was recorded. The mean of the three IOP values was used in the analyses. Results: For Observer 1, higher values of IOP with our augmented illumination against the standard were recorded, the mean difference of +0.59 mmHg being statistically significant (95% CI, 0.0 to +1.18 mmHg). For Observer 2, the mean difference of −0.22 mmHg was not significant (95% CI, −0.70 to +0.26 mmHg). Measurement times for observers were shorter when using the augmented illumination (Observer 1: mean difference = −2.0 s, S.E. = 1.4 s, CI, +0.8 to −4.9 s; Observer 2: mean difference = −5.0 s, S.E. = 1.3 s, CI, −2.5 to −7.5 s). Conclusion: The monochromatic blue light source may improve the performance of IOP measurements with the Perkins instrument under bright room conditions, making them faster and more convenient.